Jacqueline Collins

General Counsel at Terumo Neuro

Jacqueline Collins joined MicroVention as the Vice President & General Counsel in 2022. She has more than 20 years of executive management experience in legal, intellectual property, and compliance, leading global high-performing teams in both private and public companies. Jacqueline began her in-house career at Ericsson Hewlett-Packard Telecommunications, a software developer in the telecommunications industry. She then joined Nobel Biocare, as General Counsel for North America, a global medical device manufacturer in the dental industry, later adding Global Head of Intellectual Property to her responsibilities. Nobel Biocare was acquired by Danaher (NYSE: DHR) where Jacqueline worked with a team of attorneys supporting the dental division. She then joined Sonendo (NYSE: SONX) as General Counsel, a medical device manufacturer in the dental industry, named on Inc. 5000’s fastest-growing company list.

Jacqueline earned a BA in Political Science from the University of Oregon, a MA in Political Science from Rutgers University’s Eagleton Institute of Politics, a JD from the University of Oregon School of Law, and a Post Graduate Diploma in European Community Law from King’s College London. Jacqueline has lived in France and Switzerland and currently resides in Southern California.

Location

Capistrano Beach, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Terumo Neuro

1 followers

A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.


Industries

Employees

1,001-5,000

Links